Masitinib (AB1010): Product Overview
Product identity
Masitinib (AB1010) is listed by APExBIO as SKU A2942. The supplied product description identifies it as a phenylaminothiazole-type tyrosine kinase inhibitor primarily associated with KIT, PDGFRα, and PDGFRβ, with additional reported interactions involving Lyn and FGFR3. The listed molecular formula is C28H30N6OS and the molecular weight is 498.64.
Conceptual research scope
Based on the supplier description, Masitinib is positioned for conceptual work involving KIT signaling pathway inhibition, PDGFR signaling pathway inhibition, cancer biology, mast cell biology, and inflammatory disease research. These areas include research related to a tyrosine kinase inhibitor for cancer research, inhibition of mast cell degranulation, gastrointestinal stromal tumor (GIST) treatment biology, and mastocytosis research.
The product information also describes DMSO solubility and limited solubility in water and ethanol. These are documented product properties, not evidence of assay suitability or validated experimental performance.
Evidence limitations
No matched research paper or independent evidence record was supplied for this overview. Accordingly, the product description’s potency values, cellular findings, animal-model observations, clinical statements, and safety-related claims are not presented as verified outcomes. This page does not establish therapeutic efficacy, clinical suitability, selectivity across assay systems, or applicability to any particular disease model. The available information supports product identification and broad conceptual scope only, not experimental recommendations.